Published in Cancer Weekly, April 6th, 2010
"HER2 expression was investigated by immunohistochemistry in 418 GC from Germany and 506 GC from U.K.. Results were compared to clinicopathological parameters and patient survival....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.